Other languages Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-23 pm EDT			5-day change	1st Jan Change
2.55 ^USD	-2.67%		+0.79%	-30.89%

Apr. 18	Barinthus Cervical Lesions Treatment Study Meets Primary Objective -- Shares Rise After Hours	MT
Apr. 18	BarinthuBarinthus Biotherapeutics plc Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus Infections	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BarinthuBarinthus Biotherapeutics plc Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus Infections	Apr. 18
Barinthus Biotherapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20
Arbutus Biopharma Corporation and Barinthus Biotherapeutics plc Present Preliminary Data from Phase 2A Clinical Trial Combining Imdusiran with VTP-300 at AASLD	Nov. 09
Barinthus Biotherapeutics plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
CanSino Biologics Enrolls First Case in Recombinant Zoster Vaccine Trial in Canada	Nov. 09
Sector Update: Health Care Stocks Advancing Late Afternoon	23-09-25
Sector Update: Health Care	23-09-25
Vaccitech Shares Rise After Alliance Global Partners Begins Coverage With Buy Rating	23-09-25
Top Midday Gainers	23-09-25
Arbutus Biopharma Discontinues Coronavirus, Oral RNA Destabilizer Programs, Focuses on Hepatitis B Virus Treatment Assets	23-09-11
Vaccitech plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Vaccitech plc Announces Retirement of Margaret Marshall as Chief Medical Officer	23-07-26
Vaccitech plc Announces Positive Final Data EASL Congress for Phase 1B/2 HBV002 Study in Adults with Chronic Hepatitis B	23-06-21
Vaccitech plc Doses First Patient in Pca001, A Prostate Cancer Phase 1/2 Clinical Trial of Vtp-850	23-06-12
Vaccitech plc Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Vaccitech plc Announces Retirement of Chris Ellis as Chief Operating Officer, Effective October 31, 2023	23-04-28
American Depositary Receipts of European Equities Rise As Banking Sector Worries Ease	23-03-29
Vaccitech Says Trial of Chronic Hepatitis B Therapy Meets Primary, Secondary Goals	23-03-28
Receding Bank Jitters Give Modest Boost to American Depositary Receipts of European Equities	23-03-28
Vaccitech plc Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B	23-03-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Other languages

Filters